ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2022

First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data.

Maxime Boussageon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.